Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Langmann

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Der Internist|November 13, 2002
[Skin efflorescences in infectious diseases. I: Skin efflorescences in viral diseases]H Klinker, P Langmann, R Gillitzer
Deutsche Medizinische Wochenschrift (1946)|May 26, 1995
[Pyrimethamine-sulfadiazine resistant cerebral toxoplasmosis in AIDS]P Langmann, H Klinker, E Richter
Infection|July 1, 1996
Pyrimethamine alone as prophylaxis for cerebral toxoplasmosis in patients with advanced HIV infectionH Klinker, P Langmann, E Richter
Deutsche Medizinische Wochenschrift (1946)|January 16, 2004
[Bioterrorism and the lungs]M Kolb, P Langmann, K Fleischer
Antimicrobial Agents and Chemotherapy|July 1, 1996
Plasma pyrimethamine concentrations during long-term treatment for cerebral toxoplasmosis in patients with AIDSH Klinker, P Langmann, E Richter
Der Internist|January 15, 2003
[Skin exanthema in infectious illnesses. II. Skin exanthema in bacterial illnesses, dermatomycoses, epizoonoses]H Klinker, P Langmann, R Gillitzer
International Journal of Dermatology|June 1, 1997
Toxic shock syndrome in AIDSH Klinker, P Langmann, A Schwinn, et al.
Journal of Clinical Pharmacy and Therapeutics|October 24, 1998
Drug monitoring during the treatment of AIDS-associated Pneumocystis carinii pneumonia with trimethoprim-sulfamethoxazoleH Klinker, P Langmann, M Zilly, et al.
Medizinische Klinik (Munich, Germany : 1983)|December 15, 1995
[Toxic shock syndrome in AIDS]H Klinker, P Langmann, E Richter, et al.
European Journal of Medical Research|October 16, 2007
Efavirenz-therapy in HIV-patients with underlying liver disease: importance of continuous TDM of EFVA Katsounas, A Frank, H Klinker, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Der Internist|November 13, 2002
[Skin efflorescences in infectious diseases. I: Skin efflorescences in viral diseases]H Klinker, P Langmann, R Gillitzer
Deutsche Medizinische Wochenschrift (1946)|May 26, 1995
[Pyrimethamine-sulfadiazine resistant cerebral toxoplasmosis in AIDS]P Langmann, H Klinker, E Richter
Infection|July 1, 1996
Pyrimethamine alone as prophylaxis for cerebral toxoplasmosis in patients with advanced HIV infectionH Klinker, P Langmann, E Richter
Deutsche Medizinische Wochenschrift (1946)|January 16, 2004
[Bioterrorism and the lungs]M Kolb, P Langmann, K Fleischer
Antimicrobial Agents and Chemotherapy|July 1, 1996
Plasma pyrimethamine concentrations during long-term treatment for cerebral toxoplasmosis in patients with AIDSH Klinker, P Langmann, E Richter
Der Internist|January 15, 2003
[Skin exanthema in infectious illnesses. II. Skin exanthema in bacterial illnesses, dermatomycoses, epizoonoses]H Klinker, P Langmann, R Gillitzer
International Journal of Dermatology|June 1, 1997
Toxic shock syndrome in AIDSH Klinker, P Langmann, A Schwinn, et al.
Journal of Clinical Pharmacy and Therapeutics|October 24, 1998
Drug monitoring during the treatment of AIDS-associated Pneumocystis carinii pneumonia with trimethoprim-sulfamethoxazoleH Klinker, P Langmann, M Zilly, et al.
Medizinische Klinik (Munich, Germany : 1983)|December 15, 1995
[Toxic shock syndrome in AIDS]H Klinker, P Langmann, E Richter, et al.
European Journal of Medical Research|October 16, 2007
Efavirenz-therapy in HIV-patients with underlying liver disease: importance of continuous TDM of EFVA Katsounas, A Frank, H Klinker, et al.
Pageof 3